ID   OCI-Ly17
AC   CVCL_8798
SY   OCI-LY17; OCI-LY-17; OCI-Ly 17; OCI Ly17; Ly17
DR   Wikidata; Q54931769
RX   PubMed=1493476;
RX   PubMed=8574164;
RX   PubMed=11807979;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=1493476; DOI=10.3109/10428199209049823;
RA   Chang, Hong
RA   Jamal, Nazir
RA   Wang, Xin-Hua
RA   Minden, Mark David
RA   Messner, Hans August
RT   "Constitutive production of the interleukins IL-5 and IL-6 by the
RT   lymphoma cell line OCI-Ly 17 derived from a patient with malignant
RT   lymphoma and hypereosinophilia.";
RL   Leuk. Lymphoma 8:97-107(1992).
//
RX   PubMed=8574164; DOI=10.3109/10428199509059672;
RA   Chang, Hong
RA   Blondal, John A.
RA   Benchimol, Sam
RA   Minden, Mark David
RA   Messner, Hans August
RT   "p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's
RT   lymphoma cell lines.";
RL   Leuk. Lymphoma 19:165-171(1995).
//
RX   PubMed=11807979; DOI=10.1002/gcc.10025;
RA   Mehra, Sukvarsha
RA   Messner, Hans August
RA   Minden, Mark David
RA   Chaganti, Raju S.K.
RT   "Molecular cytogenetic characterization of non-Hodgkin lymphoma cell
RT   lines.";
RL   Genes Chromosomes Cancer 33:225-234(2002).
//